← All stocks

MANGOCEUTICALS, INC.

MGRX Net buying
CIK 0001938046 #5304 in the set updated 22 Sep 2026
Bought (120 mo)
$275.00K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$213.85K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$213.85K
6 of 6 sales
Net
+$61.15K
+$61.15K against sales at will

By person

7 insiders · 7 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Cohen Jacob D.
Chief Executive Officer
$275.00K (1)
+$275.00K
500,000
$582.65K
Hamilton Alex P.
Director
$192.71K (3)
−$192.71K
3,334
$3.89K
−88.2%
JOHNSTON EUGENE M
CFO
$21.14K (3)
−$21.14K
120,000
$139.84K
Hammer Amanda Elizabeth
Chief Operating Officer
175,000
$203.93K
D'Alessio Lorraine Pamela
Director
136,667
$159.26K
MYERS KENNY
Director
136,667
$159.26K
Isaac Antonios
President
60,000
$69.92K

No percentages here. This company's share count has moved by a factor of 8.7 over the window, from 2,486,512 to 21,567,422 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
JOHNSTON EUGENE M
15 Dec 2025
CFO
Sell
3,333
$1.17
$3.88K
JOHNSTON EUGENE M
9 Dec 2025
CFO
Sell
5,000
$1.20
$5.98K
JOHNSTON EUGENE M
5 Dec 2025
CFO
Sell
10,000
$1.13
$11.28K
Hamilton Alex P.
19 Nov 2025
Director
Sell
125,000
$1.22
$152.88K
Hamilton Alex P.
26 Jun 2024
Director
Sell
108,426
$0.32
$34.70K
Hamilton Alex P.
25 Jun 2024
Director
Sell
16,574
$0.31
$5.14K

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 20,785,000
History held since 2 May 2023